Home
/
SPRUCE BIOSCIENCES, INC.
/
Financials
/
Quarterly
SPRUCE BIOSCIENCES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that SPRUCE BIOSCIENCES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 10, 2025
Q2
2025
Jun 30, 2025
$0
Aug 14, 2025
Q1
2025
Mar 31, 2025
$0
May 6, 2025
Q3
2025
Sep 30, 2024
$602.0K
Nov 10, 2025
Q2
2025
Jun 30, 2024
$1.61M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$2.00M
May 6, 2025
Q3
2024
Sep 30, 2023
$3.07M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$2.17M
Aug 12, 2024
Q1
2024
Mar 31, 2023
$1.96M
May 13, 2024
Q3
2023
Sep 30, 2022
$0
Nov 13, 2023
Q2
2023
Jun 30, 2022
$0
Aug 14, 2023
Q1
2023
Mar 31, 2022
$0
May 15, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.21M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($2.07M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($14.04M)
May 6, 2025
Q3
2025
Sep 30, 2024
($8.67M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($9.18M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($11.63M)
May 6, 2025
Q3
2024
Sep 30, 2023
($12.35M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($12.82M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($12.79M)
May 13, 2024
Q3
2023
Sep 30, 2022
($11.40M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($11.87M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($11.76M)
May 15, 2023
Q3
2022
Sep 30, 2021
($11.45M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($11.77M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($9.89M)
May 11, 2022
Q3
2021
Sep 30, 2020
($9.59M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($6.45M)
Aug 10, 2021
Q3
2020
Jun 30, 2020
($6.45M)
Nov 18, 2020
Q3
2020
Mar 31, 2020
($5.17M)
Nov 18, 2020
Q1
2021
Mar 31, 2020
($5.17M)
May 12, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.23M)
Nov 10, 2025
Q2
2025
Jun 30, 2025
($2.69M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($14.49M)
May 6, 2025
Q3
2025
Sep 30, 2024
($9.41M)
Nov 10, 2025
Q2
2025
Jun 30, 2024
($10.04M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($12.63M)
May 6, 2025
Q3
2024
Sep 30, 2023
($13.66M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($13.97M)
Aug 12, 2024
Q1
2024
Mar 31, 2023
($13.20M)
May 13, 2024
Q3
2023
Sep 30, 2022
($11.56M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($11.88M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($11.73M)
May 15, 2023
Q3
2022
Sep 30, 2021
($11.40M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($11.71M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($9.82M)
May 11, 2022
Q3
2021
Sep 30, 2020
($9.56M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($6.39M)
Aug 10, 2021
Q1
2021
Mar 31, 2020
($5.13M)
May 12, 2021
Q3
2020
Sep 30, 2019
($2.56M)
Nov 18, 2020